U.S. Markets closed

Nymox Pharmaceutical Corporation (NYMX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.02+0.02 (+0.50%)
At close: 4:00PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 5202.81M
Enterprise Value 3N/A
Trailing P/E -15.17
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)632.78
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profit Margin 0.00%
Operating Margin (ttm)-3,857.89%
Management Effectiveness
Return on Assets (ttm)-563.62%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)320.5k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)88.90%
Gross Profit (ttm)110.59k
EBITDA -12.36M
Net Income Avi to Common (ttm)-12.6M
Diluted EPS (ttm)-0.26
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)1.63M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)964.27k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.88
Book Value Per Share (mrq)-0.02
Cash Flow Statement
Operating Cash Flow (ttm)-3.6M
Levered Free Cash Flow (ttm)1.08M

Trading Information

Stock Price History
Beta 1.39
52-Week Change 3-0.50%
S&P500 52-Week Change 314.06%
52 Week High 35.79
52 Week Low 31.62
50-Day Moving Average 34.00
200-Day Moving Average 33.74
Share Statistics
Avg Vol (3 month) 3256.68k
Avg Vol (10 day) 3115.97k
Shares Outstanding 550.45M
Float 28.15M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 33.76M
Short Ratio 312.53
Short % of Float 313.30%
Shares Short (prior month) 32.61M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A